Therapy Areas
Immix Biopharma names new director
29 July 2021 -

Immix Biopharma Inc, a US-based company involved in Tissue Specific Therapeutics for oncology and inflammation, announced on Wednesday that Jane Buchan, PhD is its new director.

Dr Buchan is also a director of Globe Life Inc and AGF Management Ltd. She is chief executive officer of Martlet Asset Management. She has served as CEO of PAAMCO. She started her career at JP Morgan Investment Management in the Capital Markets Group and has been an assistant professor of Finance at the Amos Tuck School of Business at Dartmouth. She has held the position of chairwoman of the board for the Chartered Alternative Investment Analyst Association and is a member of the Advisory Board for the Master of Financial Engineering Program at UCLA Anderson School of Management. She is serving as a trustee of Reed College, Portland, Oregon and University of California Irvine Foundation.

Dr Buchan holds a BA in Economics from Yale University and both a PhD and an MA in Business Economics (Finance) from Harvard University.



Related Headlines